You are here

scleroderma

Certa plans pivotal scleroderma trial after Phase II data readout

Certa plans pivotal scleroderma trial after Phase II data readout

Clinical Trials Arena

clinical trials

Flag link:

FDA clears Kyverna’s IND for scleroderma therapy

FDA clears Kyverna’s IND for scleroderma therapy

Pharmaceutical Business Review

Kyverna Therapeutics

Flag link:

Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3

Ex-Shire drug improves outcomes in autoimmune disease, setting Certa on path to phase 3

Fierce Biotech

Certa Therapeutics

autoimmune disease

clinical trials

Flag link:

Boehringer bags CHMP backing for Ofev in rare lung disease

Boehringer bags CHMP backing for Ofev in rare lung disease

Pharmaforum

Boehringer Ingelheim

Flag link:

Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial

Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial

Yahoo

Cytori Cell Therapy

Flag link:

Cytori Therapeutics - Independent Study On Scleroderma Shows Great Results

Cytori Therapeutics - Independent Study On Scleroderma Shows Great Results

Seeking Alpha

Flag link: